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EXPERIMENTAL PRODUCTION OF HYPERLIPEMIA IN RABBITS
BY COBALTOUS CHLORIDE*
RICHARD M. CAPLAN, M.D.' AND WALTER D. BLOCK, Pn.D.
In recent years several investigations have
demonstrated that cobalt (usually cobaltous
chloride), when given to experimental animals
(1—6), produces an increase in the serum lipid
concentrations. Several of the clinical reports of
cobalt-induced goiter in human patients have
made casual reference to the increased serum
lipid values determined in the patient (7, 5).
Except for the work of Bertheaux and Cophignon
(4), most of these studies have dealt mainly with
serum cholesterol determinations plus an occa-
sional reference to "lipemic serum", without
actual analysis of the sera for other lipid com-
ponents. Because of our observations of a patient
who developed extremely hypertriglyceridemic
xanthomatosis apparently due to cobalt intoxica-
tion (9), an investigation was initiated to study
the effect of cobalt on the serum lipid components
in experimental animals.
MATERIALS AND METHODS
Ten New Zealand female albino rabbits varying
in weight between 9 and 10 pounds were used in
this study. These animals were housed in in-
dividual cages, maintained on standard rabbit
chow and had access to water at all times. Sterile
solutions containing 10 mg. per ml. of anhydrous
cobaltous chloride were administered via oral,
intravenous, or intraperitoneal routes. Blood was
taken from either an ear vein or heart chamber
subsequent to a fast of 12 to 16 hours and just
before administration of the cobalt salt. Blood
specimens were allowed to clot and centrifuged
within several hours. The separated sera were
frozen at 0°C. until analyzed for the various lipid
components.
Total serum lipids were determined by the
method of Bragdon (10); total fatty acids by the
method of Albrink (11); total cholesterol by the
method of Abell et at. (12). Phospholipids were
extracted from the serum in an alcohol-ether
mixture, oxidized by the method of Youngburg
and Youngburg (13), and the phosphorus deter-
mined by the Fiske and SubbaRow procedure
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(14). Triglycerides (neutral fat) were calculated
by differences.
Free moving-boundary eleetrophoresis was
performed on the sera of rabbits 7, 9, and 10,
using veronal buffer at pH 8.6 and ionic strength
0.1 ji, according to the method of Tiselius (15).
Total protein and albumin/globulin ratios were
determined by the biuret method (16, 17).
RESULTS
Because of the fluctuations in several control
values for a particular animal, together with
large differences in hyperlipemic response from
animal to animal, one must be cautious in
interpreting these data, and accept only large
differences as significant effects. Since the small
number of animals and the wide variability of
response preclude meaningful statistical treat-
ment of the data, it is fortunate that many of the
observed effects were dramatic enough to be
convincing. The direction of the response was
sufficiently uniform that only illustrative exam-
ples will be presented.
We have been able to confirm the pattern of
change in the serum cholesterol level with the
production of lipemic serum after a single intra-
venous test dose, as first described by Caren and
Carbo (1). We were unable to demonstrate an
effect from relatively brief periods of oral ad-
ministration in 3 rabbits, but no conclusion
seems warranted because of the small numbers
and short time periods employed.
The results for rabbit 4 are given in Table I
and shown graphically in Figure 1. After the
intraperitoneal administration of two daily doses
of 40 mg of cobaltous chloride, there was approxi-
mately a 25 to 30 per cent increase in all of the
serum lipid components (2/17/61). The changes
in all lipid partitions seen on 3/25/61, after 40
mg of cobaltous chloride intraperitoneally per
day on 9 of the preceding 11 days, were striking.
The overall changes between the control level
(3/14/61) and the final experimental day
(3/25/61) were as follows: cholesterol increased
four-fold, the phospholipids five-fold, and the
triglycerides thirteen-fold!
The results for rabbits numbers 8 and 9 are
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TABLE I
Changes in serum lipid levels after intraperitoneal administration of CoC12 to rabbits
Rabbit Date Weight CoCkAdministered
Total Cho-
lesterol
Phospho-
lipids Triglycerides Total Lipids
Total
Fatty Acids
4 2/14/61
2/15/61
2/16/61
2/17/61
2/18/61
2/20/61
lbs.
10.5
10.3
mg.
0
40
40
0
m./1OO ml.
264
296
297
315
mg/ISO ml.
206
260
226
224
mg/ICC ml.
310
466
mg/lOS ml.
780
1,022
meq./liler
21.7
19.2
14.2
3/14/61
3/15/61
3/16/61
3/17/61
3/18/61
3/19/61
3/20/61
3/21/61
3/22/61
3/23/61
3/24/61
3/25/61'
11.2
9.6
40
40
40
40
0
0
40
40
40
40
40
186
560
161
810
257
3,452
604
4,823
9.5
9 6/ 6 61
6/ 7/61
6/ 8/61
6/ 9/61
6/13/612
6/20/61
10.5
10.0
10.0
10.0
9.5
9.0
52.5
50.5
49.8
271
252
339
265
163
203
284
175
262
598
817
367
696
1,053
1,440
807
17.7
36.9
51.5
22.7
Serum lactescent. Animal expired soon after blood sample was taken.
2 Serum lacteseent.
shown graphically in Figures 2 and 3 respectively.
Although the time at which the various serum
lipid components reach their maximum levels in
these two animals is different, the general pattern
of response is the same. The actual analytical
data for rabbit 9 are given in Table I to
facilitate comparison with the electrophoretic
patterns of the same rabbit, as given in Table
II. In this animal the increased cholesterol and
phospholipid might be dismissed except for the
more impressive changes in triglycerides which
were occurring simultaneously. In this instance
the peak effect, in terms of time intervals when
specimens were taken, was seen five days after
completion of the course of cobalt, and return to
baseline levels occurred within the subsequent
week. As one might expect, visible clouding of the
serum was seen in that specimen which had a
triglyceride value of 817 mg. %, but not in the
one with a triglyceride value of 598 mg. %.
Electrophoretic studies: Table II presents
quantitative data obtained from free moving-
boundary electrophoretic analyses. Figures 4,
5, and 6 are photographs of the ascending electro-
phoretic patterns from which these data were
determined. It can be seen that the lipid aberra-
tions produced by cobalt (as in rabbit 9,
Table I) are paralleled by the large and tem-
porary increases primarily in alpha2 and beta-
globulins, at the expense of albumin and gamma
globulin. When the serum lipids return to baseline
levels, the electrophoretic pattern similarly
returns to baseline levels.
DISCUSSION
Since the report of Caren and Carbo (1)
appeared in 1956, other investigations (2—6) have
confirmed the definite effect of cobalt in producing
elevation not only of serum cholesterol, but also
of phospholipid and neutral fat. Such experi-
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mental studies suggest that an analogous abnor-
mality could occur in humans. Many patients
have been given large doses of cobaltous chloride
for the treatment of anemia, but we are aware
of only three instances in the literature in which a
reversible lipid abnormality developed: (1)
Case 3 of Gross et al. (7), who developed a
goiter, had cholesterol and total lipid values of
338 mg % and 1610 mg. %, respectively, which
returned to 118 mg. % and 423 mg. %, respec-
tively, one month after cessation of therapy; (2)
a patient with cobalt-induced goiter reported by
Robey et al. (8) had grossly lipemic serum and a
cholesterol level of 694 mg. %, which dropped to
336 mg. % on the 10th day after cobalt was
stopped; (3) a patient with hyperlipemic xantho-
matosis reported by Caplan and Curtis (9) had a
total serum lipid level on admission of 7,330
mg. %, which decreased four days after cobalt
was stopped to 5,375 mg. %, consisting of 1,130
mg. % of cholesterol, 786 mg. % of phospho-
lipids, and 2,894 mg. % of neutral fat, and
continued to approach normal levels in the suc-
ceeding months. Undoubtedly, more clinical in-
stances of lipid disturbance due to the administra-
tion of cobalt would be found if sought. On the
other hand, the variability of toxic response
noted in experimental animal studies must exist
also in humans. Whether a given subject develops
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a serum lipid elevation from cobalt, and to what
degree, may depend on such factors as species,
route of administration, dose level, duration of
the insult, initial serum lipid levels, genetic
predisposition, and probably others.
The exact nature of the "lipemiagenic" injury
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FIGS. 4, 5, and 6. Free moving-boundary electrophoretie studies (see Text)
TABLE II
,Svmmary of moving boundary electrophoretic studies
Protein Globulin, % of total protein
Rabbit Date
Total A/G Ratio Total a! 7
gm. %
7 4/25 — 1.89 65.4 34.6 4.5 6.1 15.9 8.0
5/2 — 1.04 50.9 49.1 5.4 8.2 30.5 5.0
9 6/6 8.20 1.30 56.6 43.4 2.0 3.8 15.5 22.1
6/9 11.45 0.72 41.9 58.1 4.7 21.3 20.2 11.9
6/13 5.65 0.54 35.2 64.8 13.1 19.1 14.2 18.5
6/20 6.45 1.05 51.3 48.7 3.6 7.4 24.9 12.8
10 6/6 9.25 0.83 45.5 54.5 3.7 6.6 10.9 33.3
6/9 — 0.57 36.4 63.6 6.8 17.8 16.5 22.5
6/13 7.25 0.64 39.2 60.8 5.9 8.2 19.3 27.4
6/20 7.12 0.87 46.6 53.4 3.6 6.0 14.6 29.1
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caused by cobalt is not known. It seems reason-
able, in the light of varying and conflicting
evidence, to presume that it is not a simple effect,
such as damage of the alpha cells of the pancreas,
but a more general complex cellular and metabolic
lesion (4, 18). Any attempted explanation of this
toxic phenomenon must consider not only the
effect on serum cholesterol levels but also on the
other serum lipids.
Free moving-boundary electrophoretic studies
showed that in those sera in which elevation of
serum lipid fractions existed there were increases
in the alpha2 and beta globulin protein fractions.
These observations parallel the general results
found by Lever et at. (19) in their study of
patients with idiopathic hyperlipemia, and that
observed by Marrone et at. (6) in their experi-
mental production of hypercholesterolemia and
serum protein changes in rabbits after intra-
venous injections of large amounts of cobaltous
chloride.
Wang et at. (20) successfully induced hyper-
lipemia and cutaneous xanthomas in rabbits by
feeding large amounts of cholesterol for several
months. Considering the results of our study,
one might reasonably presume that chronic
poisoning by cobalt, with concomitant serum
lipid increases, could likewise be employed for
the experimental production of xanthomas, and
probably atheromas as well. Fortuitously, such
an event has occurred in the human at least
once (9).
SUMMARY
Cobaltous chloride, when administered intra-
venously or intraperitoneally to rabbits in
varying programs, resulted in large increases in
total serum lipids. The serum lipid fraction that
increased most consistently and to the greatest
extent was the triglycerides. With the increase in
the lipid concentration of the serum, parallel
increases in the alpha2 and beta serum globulins
were observed. The mechanism of the cobalt-
induced aberration in lipid metabolism is not
known.
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